Skip to main content
SpringerLink
Log in

CHRM2 but not CHRM1 or CHRM3 polymorphisms are associated with asthma susceptibility in Mexican patients

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Asthma is a complex disease for which genetic predisposition has been widely documented. Considerable evidence supports the hypothesis that polymorphisms in the muscarinic–cholinergic (CHRM) genes could be involved in asthma pathogenesis, bronchial hyperresponsiveness, and mucus secretion. To determine whether single nucleotide polymorphisms (SNPs) or haplotypes in CHRM1, CHRM2, or CHRM3 are associated with asthma in Mexican pediatric population. We performed a case–control study including 398 pediatric cases with asthma and 450 healthy controls. We analyzed 19 SNPs distributed among these three genes. Two of the seven SNPs located in CHRM2, the 3′ untranslated region rs8191992 and rs6962027, differed significantly in allele frequencies between patients with asthma and healthy controls [odds ratio (OR) 1.42, 95 % confidence interval (95 % CI) 1.14–1.77, P = 0.001, and OR 1.50, 95 % CI 1.21–1.87, P = 0.0002, respectively]. Statistical significance remained after multiple comparison corrections (P = 0.003 and P = 0.005, respectively). The haplotypes AA and TT, containing both major and minor alleles from rs8191992 and rs6962027, also differed between cases and controls. The haplotype AA occurred at a lower frequency in cases (OR 0.67, 95 % CI 0.53–0.85, P = 0.001) whereas the haplotype TT was overrepresented in cases compared to controls (28 vs 21 %, respectively; OR 1.46, 95 % CI 1.15–1.85, P = 0.002). No association was observed between CHRM1 or CHRM3 SNPs or haplotypes and asthma. CHRM2 polymorphisms are implicated in the genetic etiology of asthma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Lemanske RF Jr, Busse WW (2003) Asthma. J Allergy Clin Immunol 111:S502–S519

    Article  PubMed  CAS  Google Scholar 

  2. Buels KS, Fryer AD (2012) Muscarinic receptor antagonists: effects on pulmonary function. Handb Exp Pharmacol 208:317–341

    Article  PubMed  CAS  Google Scholar 

  3. Meurs H, Dekkers BG, Maarsingh H, Halayko AJ, Zaagsma J, Gosens R (2013) Muscarinic receptors on airway mesenchymal cells: novel findings for an ancient target. Pulm Pharmacol Ther 26:145–155

    Article  PubMed  CAS  Google Scholar 

  4. Struckmann N, Schwering S, Wiegand S et al (2003) Role of muscarinic receptor subtypes in the constriction of peripheral airways: studies on receptor-deficient mice. Mol Pharmacol 64:1444–1451

    Article  PubMed  CAS  Google Scholar 

  5. Salgado H, Bellay T, Nichols JA et al (2007) Muscarinic M2 and M1 receptors reduce GABA release by Ca2+ channel modulation through activation of PI3 K/Ca2+-independent and PLC/Ca2+-dependent PKC. J Neurophysiol 98:952–965

    Article  PubMed  CAS  Google Scholar 

  6. Oenema TA, Kolahian S, Nanninga JE et al (2010) Pro-inflammatory mechanisms of muscarinic receptor stimulation in airway smooth muscle. Respir Res 11:130

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  7. Jacoby DB, Yost BL, Kumaravel B et al (2001) Glucocorticoid treatment increases inhibitory m(2) muscarinic receptor expression and function in the airways. Am J Respir Cell Mol Biol 24:485–491

    Article  PubMed  CAS  Google Scholar 

  8. Belmonte KE (2005) Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease. Proc Am Thorac Soc 2:297–304

    Article  PubMed  CAS  Google Scholar 

  9. Gosens R, Zaagsma J, Meurs H, Halayko AJ (2006) Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res 7:73

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  10. Ikeda T, Anisuzzaman AS, Yoshiki H et al (2012) Regional quantification of muscarinic acetylcholine receptors and β-adrenoceptors in human airways. Br J Pharmacol 166:1804–1814

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  11. On LS, Boonyongsunchai P, Webb S, Davies L, Calverley PM, Costello RW (2001) Function of pulmonary neuronal M(2) muscarinic receptors in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163:1320–1325

    Article  PubMed  CAS  Google Scholar 

  12. Cao R, Dong XW, Jiang JX et al (2011) M(3) muscarinic receptor antagonist bencycloquidium bromide attenuates allergic airway inflammation, hyperresponsiveness and remodeling in mice. Eur J Pharmacol 655:83–90

    Article  PubMed  CAS  Google Scholar 

  13. Donfack J, Kogut P, Forsythe S, Solway J, Ober C (2003) Sequence variation in the promoter region of the cholinergic receptor muscarinic 3 gene and asthma and atopy. J Allergy Clin Immunol 111:527–532

    Article  PubMed  CAS  Google Scholar 

  14. Fenech AG, Ebejer MJ, Felice AE, Ellul-Micallef R, Hall IP (2001) Mutation screening of the muscarinic M(2) and M(3) receptor genes in normal and asthmatic subjects. Br J Pharmacol 133:43–48

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  15. Maeda Y, Hizawa N, Jinushi E et al (2006) Polymorphisms in the muscarinic receptor 1 gene confer susceptibility to asthma in Japanese subjects. Am J Respir Crit Care Med 174:1119–1124

    Article  PubMed  CAS  Google Scholar 

  16. Szczepankiewicz A, Breborowicz A, Sobkowiak P, Kramer L, Popiel A (2009) Association of A/T polymorphism of the CHRM2 gene with bronchodilator response to ipratropium bromide in asthmatic children. Pneumonol Alergol Pol 77:5–10

    PubMed  Google Scholar 

  17. Yamamoto T, Yamashita N, Kuwabara M et al (2002) Mutation screening of the muscarinic M2 and M3 receptor genes in asthmatics, outgrow subjects, and normal controls. Ann Genet 45:109–113

    Article  PubMed  Google Scholar 

  18. Jiménez-Morales S, Gamboa-Becerra R, Baca V et al (2012) MiR-146a polymorphism is associated with asthma but not with systemic lupus erythematosus and juvenile rheumatoid arthritis in Mexican patients. Tissue Antigens 80:317–321

    Article  PubMed  CAS  Google Scholar 

  19. Ramírez-Bello J, Jiménez-Morales S, Espinosa-Rosales F et al (2013) Juvenile rheumatoid arthritis and asthma, but not childhood-onset systemic lupus erythematosus are associated with FCRL3 polymorphisms in Mexicans. Mol Immunol 53:374–378

    Article  PubMed  CAS  Google Scholar 

  20. Luo X, Kranzler HR, Zuo L, Wang S, Blumberg HP, Gelernter J (2005) CHRM2 gene predisposes to alcohol dependence, drug dependence and affective disorders: results from an extended case-control structured association study. Hum Mol Genet 14:2421–2434

    Article  PubMed  CAS  Google Scholar 

  21. Wang JC, Hinrichs AL, Stock H et al (2004) Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome. Hum Mol Genet 13:1903–1911

    Article  PubMed  CAS  Google Scholar 

  22. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265

    Article  PubMed  CAS  Google Scholar 

  23. Del Rio-Navarro B, Del Rio-Chivardi JM, Berber A, Sienra-Monje JJ, Rosas-Vargas M, Baeza-Bacab M (2006) Asthma prevalence in children living in North Mexico City and a comparison with other Latin American cities and world regions. Allergy Asthma Proc 27:334–340

    Article  Google Scholar 

  24. Liu J, Conklin BR, Blin N, Yun J, Wess J (1995) Identification of a receptor/G-protein contact site critical for signaling specificity and G-protein activation. Proc Natl Acad Sci USA 92:11642–11646

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  25. Vogel WK, Sheehan DM, Schimerlik MI (1997) Site-directed mutagenesis on the m2 muscarinic acetylcholine receptor: the significance of Tyr403 in the binding of agonists and functional coupling. Mol Pharmacol 52:1087–1094

    PubMed  CAS  Google Scholar 

  26. Yuan HY, Chiou JJ, Tseng WH et al (2006) FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 34:W635–W641

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  27. Bowerfind WM, Fryer AD, Jacoby DB (2002) Double-stranded RNA causes airway hyperreactivity and neuronal M2 muscarinic receptor dysfunction. J Appl Physiol 92:1417–1422

    PubMed  CAS  Google Scholar 

  28. Moulton BC, Fryer AD (2011) Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD. Br J Pharmacol 163:44–52

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  29. Ogoda M, Niiya R, Koshika T, Yamada S (2001) Comparative characterization of lung muscarinic receptor binding after intratracheal administration of tiotropium, ipratropium, and glycopyrrolate. J Pharmacol Sci 115:374–382

    Article  CAS  Google Scholar 

  30. Pelaia G, Vatrella A, Gallelli L, Cazzola M, Maselli R, Marsico SA (2004) Potential genetic influences on the response to asthma treatment. Pulm Pharmacol Ther 17:253–261

    Article  PubMed  CAS  Google Scholar 

  31. Mougey EB, Chen C, Tantisira KG, Blake KV, Peters SP, Wise RA, Weiss ST, Lima JJ (2013) Pharmacogenetics of asthma controller treatment. Pharmacogenomics J 13:242–250

    Article  PubMed  CAS  Google Scholar 

  32. Guo Y, Traurig M, Ma L et al (2006) CHRM3 gene variation is associated with decreased acute insulin secretion and increased risk for early-onset type 2 diabetes in Pima Indians. Diabetes 55:3625–3629

    Article  PubMed  CAS  Google Scholar 

  33. Garbacki N, Di Valentin E, Huynh-Thu VA et al (2011) MicroRNAs profiling in murine models of acute and chronic asthma: a relationship with mRNAs targets. PLoS One 6:e16509

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  34. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297

    Article  PubMed  CAS  Google Scholar 

  35. Ricci A, Mariotta S, Amenta F, Tayebati SK, Terzano C (2008) Changes in muscarinic cholinergic receptor expression in human peripheral blood lymphocytes in allergic rhinitis patients. Pulm Pharmacol Ther 21:79–87

    Article  PubMed  CAS  Google Scholar 

  36. Larché M, Robinson DS, Kay AB (2003) The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 111:450–463

    Article  PubMed  CAS  Google Scholar 

  37. Kharitonov SA, Barnes PJ (2006) Exhaled biomarkers. Chest 130:1541–1546

    Article  PubMed  Google Scholar 

  38. Paraskakis E, Brindicci C, Fleming L et al (2006) Measurement of bronchial and alveolar nitric oxide production in normal children and children with asthma. Am J Respir Crit Care Med 174:260–267

    Article  PubMed  CAS  Google Scholar 

  39. Liu J, Blin N, Conklin BR, Wess J (1996) Molecular mechanisms involved in muscarinic acetylcholine receptor-mediated G protein activation studied by insertion mutagenesis. J Biol Chem 271:6172–6178

    Article  PubMed  CAS  Google Scholar 

  40. ten Berge RE, Santing RE, Hamstra JJ, Roffel AF, Zaagsma J (1995) Dysfunction of muscarinic M2 receptors after the early allergic reaction: possible contribution to bronchial hyperresponsiveness in allergic guinea-pigs. Br J Pharmacol 114:881–887

    Article  PubMed Central  PubMed  Google Scholar 

  41. Cohen-Woods S, Gaysina D, Craddock N, Farmer A et al (2009) Depression case control (DeCC) study fails to support involvement of the muscarinic acetylcholine receptor M2 (CHRM2) gene in recurrent major depressive disorder. Hum Mol Genet 18:1504–1509

    Article  PubMed  CAS  Google Scholar 

  42. Mobascher A, Rujescu D, Mittelstrass K et al (2010) Association of a variant in the muscarinic acetylcholine receptor 2 gene (CHRM2) with nicotine addiction. Am J Med Genet B 153B:684–690

    CAS  Google Scholar 

  43. Cannon DM, Klaver JK, Gandhi SK et al (2011) Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder. Mol Psychiatry 16:407–418

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  44. Jung MH, Park BL, Lee BC et al (2011) Association of CHRM2 polymorphisms with severity of alcohol dependence. Genes Brain Behav 10:253–256

    Article  PubMed  CAS  Google Scholar 

  45. Mak JC, Baraniuk JN, Barnes PJ (1992) Localization of muscarinic receptor subtype mRNAs in human lung. Am J Respir Cell Mol Biol 7:344–348

    Article  PubMed  CAS  Google Scholar 

  46. Lucas JL, DeYoung JA, Sadee W (2001) Single nucleotide polymorphisms of the human M1 muscarinic acetylcholine receptor gene. AAPS PharmSci 3:E31

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant from Consejo Nacional de Ciencia y Tecnología, Mexico (CONACyT): SALUD-008-2011-C01-161936. Authors would like to thanks all patients and families for their participation.

Conflict of interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

  1. Laboratory of Immunogenomics and Metabolic Diseases, Instituto Nacional de Medicina Genómica, SS, Periférico Sur 4809, Col. Arenal Tepepan, CP. 014610, Mexico City, Mexico

    Silvia Jiménez-Morales, Juan Luis Jiménez-Ruíz & Lorena Orozco

  2. Department of Allergy, Hospital Infantil de México, Mexico City, Mexico

    Blanca Estela Del Río-Navarro

  3. Division of Research, Secretaría de Salud del Estado de Guanajuato, Guanajuato, Guanajuato, Mexico

    Efraín Navarro-Olivos

  4. Blood Bank, Instituto Nacional de Pediatría, Mexico City, Mexico

    Guillermo Escamilla-Guerrero

  5. Cancer and Inflammation Program, Laboratory of Experimental Immunology, National Cancer Institute-Frederick, Frederick, MD, 21702, USA

    Ram Savan

  6. Laboratory of Experimental Immunology, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD, USA

    Michael Dean

Authors
  1. Silvia Jiménez-Morales
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juan Luis Jiménez-Ruíz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Blanca Estela Del Río-Navarro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Efraín Navarro-Olivos
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guillermo Escamilla-Guerrero
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ram Savan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Michael Dean
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Lorena Orozco
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lorena Orozco.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jiménez-Morales, S., Jiménez-Ruíz, J.L., Del Río-Navarro, B.E. et al. CHRM2 but not CHRM1 or CHRM3 polymorphisms are associated with asthma susceptibility in Mexican patients. Mol Biol Rep 41, 2109–2117 (2014). https://doi.org/10.1007/s11033-014-3060-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-014-3060-6

Keywords

Search

Navigation